Study experiences of people with glioblastoma before treatment
Part of Cancer clinical trials.
This study looks at people’s experiences when they join glioblastoma research before any treatment starts. It may help improve how future clinical research supports patients and caregivers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with glioblastoma (a type of brain tumor).
- You have not had any prior treatment for your glioblastoma.
- You can understand the study and are willing to sign consent forms.
- You are not pregnant or nursing (this study excludes females who are).
- You are not enrolled in another research study and not taking any other experimental medicines.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a new approach that aims to help your immune system recognize glioblastoma, a type of brain tumor. If you’re eligible, you may be asked to receive treatments designed to target specific tumor “antigens” (markers).
This study tests how best to measure and track glioblastoma treatment while using MRI (a body scanner) to guide radiation. It may help improve how doctors assess the radiation response during therapy.
This study aims to improve understanding of glioblastoma (and gliosarcoma) by preserving live, usable brain-tissue samples during brain surgery. If you’re having repeat tumor surgery or your scans suggest these cancers, the study may ask to collect tissue for research.
This trial looks at how to help people with glioma follow the clinical research process—like visits, tests, and treatment schedules. It’s mainly for adults who can safely take part and give consent.
This study is for adults with glioblastoma, a type of brain cancer. It is an observational study that will follow participants to learn more about the disease.
This study follows people newly diagnosed with glioblastoma to see how certain lab signals (MMP2 and MMP9) match up with MRI scan features. It may help doctors better understand the disease and how it appears on imaging, but it’s mainly observational.
Hear when a new Glioblastoma Multiforme trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.